• Je něco špatně v tomto záznamu ?

The Regulatory Role of Nuclear Factor Kappa B in the Heart of Hereditary Hypertriglyceridemic Rat

S. Vranková, A. Barta, J. Klimentová, I. Dovinová, S. Líšková, Z. Dobešová, O. Pecháňová, J. Kuneš, J. Zicha,

. 2016 ; 2016 (-) : 9814038. [pub] 20160411

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc17013880

Grantová podpora
NV15-25396A MZ0 CEP - Centrální evidence projektů

Activation of nuclear factor-κB (NF-κB) by increased production of reactive oxygen species (ROS) might induce transcription and expression of different antioxidant enzymes and also of nitric oxide synthase (NOS) isoforms. Thus, we aimed at studying the effect of NF-κB inhibition, caused by JSH-23 (4-methyl-N (1)-(3-phenyl-propyl)-benzene-1,2-diamine) injection, on ROS and NO generation in hereditary hypertriglyceridemic (HTG) rats. 12-week-old, male Wistar and HTG rats were treated with JSH-23 (bolus, 10 μmol, i.v.). After one week, blood pressure (BP), superoxide dismutase (SOD) activity, SOD1, endothelial NOS (eNOS), and NF-κB (p65) protein expressions were higher in the heart of HTG rats compared to control rats. On the other hand, NOS activity was decreased. In HTG rats, JSH-23 treatment increased BP and heart conjugated dienes (CD) concentration (measured as the marker of tissue oxidative damage). Concomitantly, SOD activity together with SOD1 expression was decreased, while NOS activity and eNOS protein expression were increased significantly. In conclusion, NF-κB inhibition in HTG rats led to decreased ROS degradation by SOD followed by increased oxidative damage in the heart and BP elevation. In these conditions, increased NO generation may represent rather a counterregulatory mechanism activated by ROS. Nevertheless, this mechanism was not sufficient enough to compensate BP increase in HTG rats.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17013880
003      
CZ-PrNML
005      
20170418103355.0
007      
ta
008      
170413s2016 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1155/2016/9814038 $2 doi
035    __
$a (PubMed)27148433
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Vranková, Stanislava $u Institute of Normal and Pathological Physiology and Centre of Excellence for Regulatory Role of Nitric Oxide in Civilization Diseases, Slovak Academy of Sciences, 813 71 Bratislava, Slovakia.
245    14
$a The Regulatory Role of Nuclear Factor Kappa B in the Heart of Hereditary Hypertriglyceridemic Rat / $c S. Vranková, A. Barta, J. Klimentová, I. Dovinová, S. Líšková, Z. Dobešová, O. Pecháňová, J. Kuneš, J. Zicha,
520    9_
$a Activation of nuclear factor-κB (NF-κB) by increased production of reactive oxygen species (ROS) might induce transcription and expression of different antioxidant enzymes and also of nitric oxide synthase (NOS) isoforms. Thus, we aimed at studying the effect of NF-κB inhibition, caused by JSH-23 (4-methyl-N (1)-(3-phenyl-propyl)-benzene-1,2-diamine) injection, on ROS and NO generation in hereditary hypertriglyceridemic (HTG) rats. 12-week-old, male Wistar and HTG rats were treated with JSH-23 (bolus, 10 μmol, i.v.). After one week, blood pressure (BP), superoxide dismutase (SOD) activity, SOD1, endothelial NOS (eNOS), and NF-κB (p65) protein expressions were higher in the heart of HTG rats compared to control rats. On the other hand, NOS activity was decreased. In HTG rats, JSH-23 treatment increased BP and heart conjugated dienes (CD) concentration (measured as the marker of tissue oxidative damage). Concomitantly, SOD activity together with SOD1 expression was decreased, while NOS activity and eNOS protein expression were increased significantly. In conclusion, NF-κB inhibition in HTG rats led to decreased ROS degradation by SOD followed by increased oxidative damage in the heart and BP elevation. In these conditions, increased NO generation may represent rather a counterregulatory mechanism activated by ROS. Nevertheless, this mechanism was not sufficient enough to compensate BP increase in HTG rats.
650    _2
$a zvířata $7 D000818
650    _2
$a krevní tlak $x účinky léků $7 D001794
650    _2
$a tělesná hmotnost $x účinky léků $7 D001835
650    _2
$a exprese genu $x účinky léků $7 D015870
650    _2
$a glutathion $x analýza $7 D005978
650    _2
$a srdeční komory $x metabolismus $7 D006352
650    _2
$a hyperlipoproteinemie typ IV $x patologie $x veterinární $7 D006953
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a myokard $x metabolismus $7 D009206
650    _2
$a oxid dusnatý $x metabolismus $7 D009569
650    _2
$a synthasa oxidu dusnatého $x genetika $x metabolismus $7 D019001
650    _2
$a synthasa oxidu dusnatého, typ III $x genetika $x metabolismus $7 D052250
650    _2
$a oxidační stres $x účinky léků $7 D018384
650    _2
$a fenylendiaminy $x farmakologie $7 D010655
650    _2
$a krysa rodu Rattus $7 D051381
650    _2
$a potkani Wistar $7 D017208
650    _2
$a reaktivní formy kyslíku $x metabolismus $7 D017382
650    _2
$a superoxiddismutasa $x genetika $x metabolismus $7 D013482
650    _2
$a transkripční faktor RelA $x genetika $x metabolismus $7 D051996
655    _2
$a časopisecké články $7 D016428
700    1_
$a Barta, Andrej $u Institute of Normal and Pathological Physiology and Centre of Excellence for Regulatory Role of Nitric Oxide in Civilization Diseases, Slovak Academy of Sciences, 813 71 Bratislava, Slovakia.
700    1_
$a Klimentová, Jana $u Institute of Normal and Pathological Physiology and Centre of Excellence for Regulatory Role of Nitric Oxide in Civilization Diseases, Slovak Academy of Sciences, 813 71 Bratislava, Slovakia.
700    1_
$a Dovinová, Ima $u Institute of Normal and Pathological Physiology and Centre of Excellence for Regulatory Role of Nitric Oxide in Civilization Diseases, Slovak Academy of Sciences, 813 71 Bratislava, Slovakia.
700    1_
$a Líšková, Silvia $u Institute of Physiology, Academy of Sciences of the Czech Republic, 142 20 Prague 4, Czech Republic; Centre of Cardiovascular Research, 142 20 Prague 4, Czech Republic.
700    1_
$a Dobešová, Zdenka $u Institute of Physiology, Academy of Sciences of the Czech Republic, 142 20 Prague 4, Czech Republic; Centre of Cardiovascular Research, 142 20 Prague 4, Czech Republic.
700    1_
$a Pecháňová, Oľga $u Institute of Normal and Pathological Physiology and Centre of Excellence for Regulatory Role of Nitric Oxide in Civilization Diseases, Slovak Academy of Sciences, 813 71 Bratislava, Slovakia.
700    1_
$a Kuneš, Jaroslav $u Institute of Physiology, Academy of Sciences of the Czech Republic, 142 20 Prague 4, Czech Republic; Centre of Cardiovascular Research, 142 20 Prague 4, Czech Republic.
700    1_
$a Zicha, Josef $u Institute of Physiology, Academy of Sciences of the Czech Republic, 142 20 Prague 4, Czech Republic; Centre of Cardiovascular Research, 142 20 Prague 4, Czech Republic.
773    0_
$w MED00180520 $t Oxidative medicine and cellular longevity $x 1942-0994 $g Roč. 2016, č. - (2016), s. 9814038
856    41
$u https://pubmed.ncbi.nlm.nih.gov/27148433 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20170413 $b ABA008
991    __
$a 20170418103703 $b ABA008
999    __
$a ok $b bmc $g 1200345 $s 974658
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 2016 $c - $d 9814038 $e 20160411 $i 1942-0994 $m Oxidative medicine and cellular longevity $n Oxid Med Cell Longev $x MED00180520
GRA    __
$a NV15-25396A $p MZ0
LZP    __
$a Pubmed-20170413

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...